India, Nov. 10 -- Last Updated on November 10, 2026 12:19 am by INDIAN AWAAZ Asad Mirza Israel's election has handed Gadi Eisenkot an opening, not a government. His effort to replace Benjamin Netany... Read More
China, Nov. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Physical Activity Promotes Active Aging: An Exploration of Intrinsic Mechanisms and Pra... Read More
China, Nov. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Four-Party Collaborative Post-Discharge Follow-up and Whole-Course Health Management ... Read More
China, Nov. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Multi-omics Integration Model of Genome (cfDNA) - Transcriptome (cfRNA) - Radiomics: Pr... Read More
China, Nov. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Population pharmacokinetic modeling and individualized medication study of voriconazole... Read More
China, Nov. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Construction and Preliminary Application of a Decision Aid for Health Behavior in Patie... Read More
China, Nov. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Photoprotective Efficacy and Safety of Two High-SPF Broad-Spectrum Sunscreens in Patien... Read More
China, Nov. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Association between the severity of coronary artery calcification determined by ordinal... Read More
China, Nov. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Using Machine Learning to Build a Venous Thromboembolism Screening Model for Older Adul... Read More
China, Nov. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Clinical Study of SHR-1701 Combined with Apatinib as Second-Line Therapy for Advanced... Read More